PRODYGY is a clinical study evaluating the potential of an investigational drug called SPVN06 for the treatment of retinitis pigmentosa (RP).
Join the Study
How to join the PRODYGY clinical study
If you are interested in participating, please contact the study clinical coordinator at the nearest investigational site below.
Taking part in a clinical research study involves risks, and not all risks are identified for the investigational drug yet. You may experience side effects and discomforts. Learn more about how we protect your safety.
It is up to you to decide whether you join a clinical study. You will be asked to provide your informed consent before you can join a clinical study. Learn more about what is informed consent.
